Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Max Hoebink, et al, adding:
”Clinical Applicability of Anti-Xa Measurements to Monitor Unfractionated Heparin Activity During Arterial Procedures: A Scoping Review
This scoping review of 55 reports finds that while anti-Xa is a reliable reference test for heparin monitoring during arterial procedures, optimal target levels and their correlation with clinical outcomes remain poorly defined.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Tom Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion
-
Oct 18, 2026, 12:14Abhi Kapuria: When VTE Prophylaxis Breaks Down in the ICU
-
Oct 18, 2026, 11:37Lee Anne Sorto: Beyond Compliance – Making Audits Count in Transfusion Safety
-
Oct 18, 2026, 11:26Valentina Ajello: Does ANH Benefit Women in Cardiac Surgery?
-
Oct 18, 2026, 11:06Alex Ballout: Novel FUT1 Variant Linked to a Rare H-Deficient Blood Phenotype
-
Oct 18, 2026, 10:51Lethukwenama Letsoalo: Why Women’s Iron Status Matters Before Childbirth